AB 2418, as amended, Bonilla. Health care coverage: prescription drugs: refills.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law also provides for the regulation of health insurers by the Department of Insurance. Existing law imposes various requirements on contracts and policies that cover prescription drug benefits. Existing law, the Pharmacy Law, provides for the licensure and regulation of pharmacists by the California State Board of Pharmacy and prohibits the refilling of a prescription without the authorization of the prescriber, except as specified.
This bill would require a health care service plan contract or health insurance policy issued, amended, or renewed on or after January 1, 2016, that provides coverage for prescription drug benefits and imposes a mandatory mail-order restriction for all or some covered prescription drugs to establish a process allowing enrollees and insureds to opt out of the restriction, as specified. The bill would require a health care service plan contract or a health insurance policy issued, amended, or renewed on or after January 1, 2016, that provides coverage for prescription drug benefits to permit and apply a prorated daily cost-sharing rate to refills of prescriptions that are dispensed by a participating pharmacy for less than the standard refill amount if the prescriber or pharmacist indicates that the refill is in the best interest of the enrollee or insured and is for the purpose of synchronizing the refill dates of the enrollee’s or insured’s medications, provided that certain requirements are satisfied. The bill would also require a health care service plan contract or health insurance policy issued, amended, or renewed on or after January 1, 2016, that provides coverage for prescription drug benefits to allow for the early refill of covered topical ophthalmic products at 70% of the predicted days of use. Because a willful violation of the bill’s requirements by a health care service plan would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Vote: majority. Appropriation: no. Fiscal committee: yes. State-mandated local program: yes.
The people of the State of California do enact as follows:
The Legislature hereby finds and declares all of
2the following:
3(a) Asbegin delete muchend deletebegin insert manyend insert as 75 percent of patients do not take their
4medications as prescribed. Poor adherence to prescribed treatments
5poses serious health risks to nonadhering patients, particularly
6those with chronic diseases.
7(b) Poor adherence to prescribed treatments leads to unnecessary
8disease progression, avoidable utilization of inpatient and outpatient
9medical
care, higher mortality rates, and increased medical
10spending. According to the New England Healthcare Institute,
11poor adherence to medication results in $100 billion in excess
12hospital visits and a total of $290 billion in avoidable medical
P3 1spending each year -- 13 percent of all health care expenditures
2in the United States. Adherence to prescription medication prevents
3these unnecessary complications and is a cost-effective and simple
4tool in the treatment of health conditions.
5(c) Given the evidence showing benefits to patients, the federal
6Centers for Medicare and Medicaid Services requires Medicare
7Part D plans to permit beneficiaries to choose between mail-order
8delivery or community pharmacy access to prescription drugs,
9requires Part D plans to allow for the synchronization of refill dates
10for patients with multiple prescriptions, and
recommends that Part
11D plans authorize early refills of topical ophthalmic products at
1270 percent of the predicted days of use.
13(d) It is the intent of the Legislature to enact legislation that
14promotes policies designed to improve patient medication
15
adherence.
Section 1367.247 is added to the Health and Safety
17Code, to read:
(a) A health care service plan contract issued,
19amended, or renewed on or after January 1, 2016, that provides
20coverage for prescription drug benefits and that imposes a
21mandatory mail-order restriction for some or all covered
22prescription drugs shall establish a process for enrollees to opt out
23of that restriction. The opt out process may require the use of a
24plan’s participating pharmacy thatbegin insert is not a mail-order-only
25pharmacyend insert, at the discretion of thebegin delete plan, is suited to special handling begin insert
planend insert. The opt out process
26of the prescription drug and patient careend delete
27may require 30 days’ written notice before the election to opt out
28is effective. The opt out process shall comply with all of the
29following requirements:
30(1) Not impose conditions or restrictions on an enrollee opting
31out of the mandatory mail-order restriction. For purposes of this
32subparagraph, “conditions or restrictions” include, but are not
33limited to, requiring prescriber approval or submission of
34documentation by the enrollee or prescriber.
35(2) Allow an enrollee to opt out of the mandatory mail-order
36restriction, and revoke his or her prior opt out of the restriction, at
37any time.
38(3) The choice by an enrollee to opt out shall be valid for the
39duration of the plan
year or until the enrollee elects to revoke the
40opt out, whichever occurs first, provided that the enrollee remains
P4 1enrolled in the same product with either the same subscriber, with
2respect to individual plan contracts, or the same plan sponsor, with
3respect to group plan contracts.
4(4) A health care service plan shall provide an enrollee who
5obtains a covered prescription drug that is subject to the mandatory
6mail-order restriction with a separate written notice of the
7restriction and any exceptions upon dispensing of the first fill of
8the drug or no less than 30 days prior to the restriction taking effect
9for the first refill of the drug. This written notice shall be in addition
10to any information contained in the plan’s evidence of coverage
11or evidence of benefits. The notice shall inform the enrollee of the
12right to opt out of the
mandatory mail-order restriction and
13instructions on how to do so.
14(b) This section shall not apply to a drug that is not available at
15a participating community pharmacy due to any of the following:
16(1) An industry shortage listed on the Current Drug Shortages
17Index maintained by the federal Food and Drug Administration
18(FDA).
19(2) A manufacturer’s instructions or restrictions.
20(3) Any risk evaluation and management strategy approved by
21the FDA.
22(4) A special shortage affecting the plan’s network of
23participating pharmacies.
24(c) Nothing in this section shall be construed to establish a new
25
mandated benefit or to prevent the application of deductible or
26copayment provisions in a plan contract.
27(d) Nothing in this section shall be construed to limit or prohibit
28differential copayments in the form of financial incentives whereby
29an enrollee’s cost sharing is reduced when he or she uses mail
30order rather than a community pharmacy.
31(e) For purposes of this section, the following definitions shall
32apply:
33(1) For group health care service plan contracts, “plan year” has
34the meaning set forth in Section 144.103 of Title 45 of the Code
35of Federal Regulations.
36(2) For individual health care service plan contracts, “plan year”
37means the
calendar year.
Section 1367.248 is added to the Health and Safety
39Code, to read:
(a) A health care service plan contract issued,
2amended, or renewed on or after January 1, 2016, that provides
3coverage for prescription drug benefits shall permit and apply a
4prorated daily cost-sharing rate to the refills of prescriptions that
5are dispensed by a participating pharmacy for less than the standard
6refill amount if the prescriber or pharmacist indicates that the refill
7for less than the standard amount is in the best interest of the
8enrollee and is for the purpose of synchronizing the refill dates of
9the enrollee’s medications and all of the following apply:
10(1) The prescription drugs being synchronized are covered and
11authorized by the health
care service plan contract.
12(2) The prescription drugs being refilled for less than the
13standard amount are not subject to quantity limits or other
14utilization management controls that are inconsistent with the
15synchronization plan, including, but not limited to, controlled
16substance prescribing and dispensing guidelines intended to prevent
17misuse or abuse.
18(3) The prescription drugs being synchronized are dispensed
19by a single participating pharmacy.
20(4) The patient has completed at least 90 consecutive days on
21the prescription drugs being synchronized.
22(5) The prescription drugs being refilled for less than the
23standard amount are of a formulation that can
be effectively split
24over the required short fill period to achieve synchronization.
25(6) The prescriber has not done either of the following with
26respect to thebegin delete prescriptionsend deletebegin insert prescriptionend insert drugs being refilled for
27less than the standard amount:
28(A) Indicated, either orally or in his or her own handwriting,
29“No change to quantity,” or words of similar meaning.
30(B) Checked a box on the prescription marked “No change to
31quantity,” and personally initialed the box or checkmark.
32(b) This section
shall not apply to a drug that is not available at
33a participating community pharmacy due to any of the following:
34(1) An industry shortage listed on the Current Drug Shortages
35Index maintained by the federal Food and Drug Administration
36(FDA).
37(2) A manufacturer’s instructions or restrictions.
38(3) Any risk evaluation and management strategy approved by
39the FDA.
P6 1(4) A special shortage affecting the plan’s
network of
2participating pharmacies.
3(c) Nothing in this section shall be construed to establish a new
4or mandated benefit or to prevent the application of deductible or
5copayment provisions in a plan contract.
Section 1367.249 is added to the Health and Safety
7Code, to read:
(a) A health care service plan contract issued,
9amended, or renewed on or after January 1, 2016, that provides
10coverage for prescription drug benefits shall allow for early refills
11of covered topical ophthalmic products at 70 percent of the
12predicted days of use.
13(b) Nothing in this section shall be construed to establish a new
14mandated benefit or to prevent the application of deductible or
15copayment provisions in a plan contract.
Section 10123.207 is added to the Insurance Code, to
17read:
(a) A health insurance policy issued, amended, or
19renewed on or after January 1, 2016, that provides coverage for
20prescription drug benefits and that imposes a mandatory mail-order
21restriction for some or all covered prescription drugs shall establish
22a process for insureds to opt out of that restriction. The opt out
23process may require the use of a plan’s participating pharmacy
24thatbegin insert is not a mail-order-only pharmacyend insert, at the discretion of the
25begin delete plan, is suited to special handling of the prescription drug and begin insert
planend insert. The opt out process may require 30 days’ written
26patient careend delete
27notice before the election to opt out is effective. The opt out process
28shall comply with all of the following requirements:
29(1) Not impose conditions or restrictions on an insured opting
30out of the mandatory mail-order restriction. For purposes of this
31subparagraph, “conditions or restrictions” include, but are not
32limited to, requiring prescriber approval or submission of
33documentation by the insured or prescriber.
34(2) Allow an insured to opt out of the mandatory mail-order
35restriction, and revoke his or her prior opt out of the restriction, at
36any time.
37(3) The choice by an insured to opt out shall be valid for the
38duration of the
plan year or until the insured elects to revoke the
39opt out, whichever occurs first, provided that the insured remains
40enrolled in the same product with either the same policyholder,
P7 1with respect to individual policies, or the same plan sponsor, with
2respect to group policies.
3(4) A health insurer shall provide an insured who obtains a
4covered prescription drug that is subject to the mandatory
5mail-order restriction with a separate written notice of the
6restriction and any exceptions upon dispensing of the first fill of
7the drug or no less than 30 days prior to the restriction taking effect
8for the first refill of the drug. This written notice shall be in addition
9to any information contained in the insurer’s evidence of coverage
10or evidence of benefits. The notice shall inform the insured of the
11right to opt out of the mandatory mail-order
restriction and
12instructions on how to do so.
13(b) This section shall not apply to a drug that is not available at
14a participating community pharmacy due to any of the following:
15(1) An industry shortage listed on the Current Drug Shortages
16Index maintained by the federal Food and Drug Administration
17(FDA).
18(2) A manufacturer’s instructions or restrictions.
19(3) Any risk evaluation and management strategy approved by
20the FDA.
21(4) A special shortage affecting the insurer’s network of
22participating pharmacies.
23(c) Nothing in
this section shall be construed to establish a new
24
mandated benefit or to prevent the application of deductible or
25copayment provisions in a policy.
26(d) Nothing in this section shall be construed to limit or prohibit
27differential copayments in the form of financial incentives whereby
28an insured’s cost sharing is reduced when he or she uses mail order
29rather than a community pharmacy.
30(e) For purposes of this section, the following definitions shall
31apply:
32(1) For group health insurance policies, “plan year” has the
33meaning set forth in Section 144.103 of Title 45 of the Code of
34Federal Regulations.
35(2) For individual health insurance policies, “plan year” means
36the calendar
year.
Section 10123.208 is added to the Insurance Code, to
38read:
(a) A health insurance policy issued, amended, or
40renewed on or after January 1, 2016, that provides coverage for
P8 1prescription drug benefits shall permit and apply a prorated daily
2cost-sharing rate to the refills of prescriptions that are dispensed
3by a participating pharmacy for less than the standard refill amount
4if the prescriber or pharmacist indicates that the refill for less than
5the standard amount is in the best interest of the insured and is for
6the purpose of synchronizing the refill dates of the insured’s
7medications and all of the following apply:
8(1) The prescription drugs being synchronized are covered and
9authorized by the health insurance policy.
10(2) The prescription drugs being refilled for less than the
11standard amount are not subject to quantity limits or other
12utilization management controls that are inconsistent with the
13synchronization plan, including, but not limited to, controlled
14substance prescribing and dispensing guidelines intended to prevent
15misuse or abuse.
16(3) The prescription drugs being synchronized are dispensed
17by a single participating pharmacy.
18(4) The insured has completed at least 90 consecutive days on
19the prescription drugs being synchronized.
20(5) The prescription drugs being refilled for less than the
21standard amount are of a formulation that can be effectively split
22over
the required short fill period to achieve synchronization.
23(6) The prescriber has not done either of the following with
24respect to thebegin delete prescriptionsend deletebegin insert prescriptionend insert drugs being refilled for
25less than the standard amount:
26(A) Indicated, either orally or in his or her own handwriting,
27“No change to quantity,” or words of similar meaning.
28(B) Checked a box on the prescription marked “No change to
29quantity,” and personally initialed the box or checkmark.
30(b) This section shall not apply to a drug that is not
available at
31a participating community pharmacy due to any of the following:
32(1) An industry shortage listed on the Current Drug Shortages
33Index maintained by the federal Food and Drug Administration
34(FDA).
35(2) A manufacturer’s instructions or restrictions.
36(3) Any risk evaluation and management strategy approved by
37the FDA.
38(4) A special shortage affecting the insurer’s
network of
39participating pharmacies.
P9 1(c) Nothing in this section shall be construed to establish a new
2or mandated benefit or to prevent the application of deductible or
3copayment provisions in a policy.
Section 10123.209 is added to the Insurance Code, to
5read:
(a) A health insurance policy issued, amended, or
7renewed on or after January 1, 2016, that provides coverage for
8prescription drug benefits shall allow for early refills of covered
9topical opthalmic products at 70 percent of the predicted days of
10use.
11(b) Nothing in this section shall be construed to establish a new
12mandated benefit or to prevent the application of deductible or
13copayment provisions in a policy.
No reimbursement is required by this act pursuant to
15Section 6 of Article XIII B of the California Constitution because
16the only costs that may be incurred by a local agency or school
17district will be incurred because this act creates a new crime or
18infraction, eliminates a crime or infraction, or changes the penalty
19for a crime or infraction, within the meaning of Section 17556 of
20the Government Code, or changes the definition of a crime within
21the meaning of Section 6 of Article XIII B of the California
22Constitution.
O
96